Home|Journals|Articles by Year|Audio Abstracts

Original Article

Novel hydroxycinnamamide from morpholine and pyrrolidine: Synthesis, characterization, docking study, and anticancer activity against P388 leukemia murine cells

Firdaus, Nunuk Hariani Soekamto, Syadza Firdausiah, Herlina Rasyid, Nur Asmi, Muzdalifah Waelulu.

Cited by 6 Articles

This study aimed to synthesize N-(p-coumaroyl)morpholine (6a), N-caffeoylmorpholine (6b), N-(p-coumaroyl) pyrrolidine (7a), and N-caffeoylpyrrolidine (7b) from p-coumaric and caffeic acid through acetylation, chlorination, amidation, and deacetylation reactions. The characterization of these compounds was committed by Fourier transform infra-red and NMR spectroscopy, while the anticancer activity was studied against murine leukemia P388 cells. Compounds 6a, 6b, and 7b were found to have remarkable anticancer activity with IC50 values ≤ 50 μg/ml. Furthermore, 6b performed very active anticancer activity with IC50 of 1.48 μg/ml. The molecular docking study of compound 6b against the Top1 protein receptor showed the presence of hydrogen bond interactions on Asn722 and Thr718 amino acid residue. Thus, these compounds are promising candidates as anticancer agents.

Key words: amidation, caffeic acid, cytotoxic, molecular docking, p-coumaric acid

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.